Global Nuclear Medicine/Radiopharmaceuticals Sales Market Report 2018 by Manufacturer, Region, Type and Application

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Nuclear Medicine/Radiopharmaceuticals Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Diagnostic (SPECT - Technetium, PET - F-18) Market Performance (Volume)
  • 2.1.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Diagnostic (SPECT - Technetium, PET - F-18) Market Performance (Value)
  • 2.1.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Oncology Market Performance (Volume)
  • 3.1.2 Thyroid Market Performance (Volume)
  • 3.1.3 Cardiology Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Cardinal Health
  • 4.1.1 Cardinal Health Profiles
  • 4.1.2 Cardinal Health Product Information
  • 4.1.3 Cardinal Health Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.1.4 Cardinal Health Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.2 Mallinckrodt
  • 4.2.1 Mallinckrodt Profiles
  • 4.2.2 Mallinckrodt Product Information
  • 4.2.3 Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.2.4 Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.3 GE Healthcare
  • 4.3.1 GE Healthcare Profiles
  • 4.3.2 GE Healthcare Product Information
  • 4.3.3 GE Healthcare Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.3.4 GE Healthcare Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.4 Lantheus Medical Imaging
  • 4.4.1 Lantheus Medical Imaging Profiles
  • 4.4.2 Lantheus Medical Imaging Product Information
  • 4.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.5 Bayer
  • 4.5.1 Bayer Profiles
  • 4.5.2 Bayer Product Information
  • 4.5.3 Bayer Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.5.4 Bayer Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.6 Bracco Imaging
  • 4.6.1 Bracco Imaging Profiles
  • 4.6.2 Bracco Imaging Product Information
  • 4.6.3 Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.6.4 Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.7 Eczacibasi-Monrol Nuclear Products
  • 4.7.1 Eczacibasi-Monrol Nuclear Products Profiles
  • 4.7.2 Eczacibasi-Monrol Nuclear Products Product Information
  • 4.7.3 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.7.4 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.8 Nordion
  • 4.8.1 Nordion Profiles
  • 4.8.2 Nordion Product Information
  • 4.8.3 Nordion Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.8.4 Nordion Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.9 Advanced Accelerator Applications
  • 4.9.1 Advanced Accelerator Applications Profiles
  • 4.9.2 Advanced Accelerator Applications Product Information
  • 4.9.3 Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.9.4 Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.10 IBA Molecular Imaging
  • 4.10.1 IBA Molecular Imaging Profiles
  • 4.10.2 IBA Molecular Imaging Product Information
  • 4.10.3 IBA Molecular Imaging Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.10.4 IBA Molecular Imaging Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 USA Market Performance for Manufacturers
  • 6.2.1 USA Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 USA Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 USA Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 USA Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 Europe Market Performance for Manufacturers
  • 6.3.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 Europe Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 Europe Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Japan Market Performance for Manufacturers
  • 6.4.1 Japan Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Japan Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Japan Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Japan Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Korea Market Performance for Manufacturers
  • 6.5.1 Korea Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Korea Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Korea Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Korea Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 India Market Performance for Manufacturers
  • 6.6.1 India Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 India Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 India Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 India Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Southeast Asia Market Performance for Manufacturers
  • 6.7.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 South America Market Performance for Manufacturers
  • 6.8.1 South America Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 South America Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 South America Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Global Nuclear Medicine/Radiopharmaceuticals Market Performance (Sales Point)

• 7.1 Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) by Regions 2013-2018
• 7.4 Global Nuclear Medicine/Radiopharmaceuticals Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 USA Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Korea Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 India Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Oncology Industry
• 11.2 Thyroid Industry
• 11.3 Cardiology Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 China Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 USA Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Japan Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Korea Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 India Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 South America Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Diagnostic (SPECT - Technetium, PET - F-18) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Oncology Sales and and Growth Rate 2019-2024
  • 12.4.3 Thyroid Sales and and Growth Rate 2019-2024
  • 12.4.4 Cardiology Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Global Nuclear Medicine/Radiopharmaceuticals Gross Profit Trend 2019-2024

13 Conclusion